1-(3-bromophenyl)-6-ethoxypyrazolo[4,3-c]pyridine-3-carboxamide;6-ethoxy-1-[3-[2-[(3R)-3-hydroxy-1-methyl-2-oxopyrrolidin-3-yl]ethynyl]phenyl]pyrazolo[4,3-c]pyridine-3-carboxamide;(3R)-3-ethynyl-3-hydroxy-1-methylpyrrolidin-2-one
C44H43BrN10O8 — CID 161136512
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-(3-bromophenyl)-6-ethoxypyrazolo[4,3-c]pyridine-3-carboxamide;6-ethoxy-1-[3-[2-[(3R)-3-hydroxy-1-methyl-2-oxopyrrolidin-3-yl]ethynyl]phenyl]pyrazolo[4,3-c]pyridine-3-carboxamide;(3R)-3-ethynyl-3-hydroxy-1-methylpyrrolidin-2-one
1-(3-bromophenyl)-6-ethoxypyrazolo[4,3-c]pyridine-3-carboxamide;6-ethoxy-1-[3-[2-[(3R)-3-hydroxy-1-methyl-2-oxopyrrolidin-3-yl]ethynyl]phenyl]pyrazolo[4,3-c]pyridine-3-carboxamide;(3R)-3-ethynyl-3-hydroxy-1-methylpyrrolidin-2-one (PubChem CID 161136512) has the molecular formula C44H43BrN10O8 and a molecular weight of 919.79 g/mol. Its IUPAC name is 1-(3-bromophenyl)-6-ethoxypyrazolo[4,3-c]pyridine-3-carboxamide;6-ethoxy-1-[3-[2-[(3R)-3-hydroxy-1-methyl-2-oxopyrrolidin-3-yl]ethynyl]phenyl]pyrazolo[4,3-c]pyridine-3-carboxamide;(3R)-3-ethynyl-3-hydroxy-1-methylpyrrolidin-2-one.
Molecular Properties
| Compound Name | 1-(3-bromophenyl)-6-ethoxypyrazolo[4,3-c]pyridine-3-carboxamide;6-ethoxy-1-[3-[2-[(3R)-3-hydroxy-1-methyl-2-oxopyrrolidin-3-yl]ethynyl]phenyl]pyrazolo[4,3-c]pyridine-3-carboxamide;(3R)-3-ethynyl-3-hydroxy-1-methylpyrrolidin-2-one |
|---|---|
| PubChem CID | 161136512 |
| Molecular Formula | C44H43BrN10O8 |
| Molecular Weight | 919.79 g/mol |
| Exact Mass | 918.24 |
| IUPAC Name | 1-(3-bromophenyl)-6-ethoxypyrazolo[4,3-c]pyridine-3-carboxamide;6-ethoxy-1-[3-[2-[(3R)-3-hydroxy-1-methyl-2-oxopyrrolidin-3-yl]ethynyl]phenyl]pyrazolo[4,3-c]pyridine-3-carboxamide;(3R)-3-ethynyl-3-hydroxy-1-methylpyrrolidin-2-one |
| SMILES | C#C[C@]1(O)CCN(C)C1=O.CCOc1cc2c(cn1)c(C(N)=O)nn2-c1cccc(Br)c1.CCOc1cc2c(cn1)c(C(N)=O)nn2-c1cccc(C#C[C@]2(O)CCN(C)C2=O)c1 |
| InChI | InChI=1S/C22H21N5O4.C15H13BrN4O2.C7H9NO2/c1-3-31-18-12-17-16(13-24-18)19(20(23)28)25-27(17)15-6-4-5-14(11-15)7-8-22(30)9-10-26(2)21(22)29;1-2-22-13-7-12-11(8-18-13)14(15(17)21)19-20(12)10-5-3-4-9(16)6-10;1-3-7(10)4-5-8(2)6(7)9/h4-6,11-13,30H,3,9-10H2,1-2H3,(H2,23,28);3-8H,2H2,1H3,(H2,17,21);1,10H,4-5H2,2H3/t22-;;7-/m0.0/s1 |
| InChIKey | UMWILRWPJWQSOF-CVMJYUMTSA-N |
| XLogP | 2.76 |
| TPSA | 247.14 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 14 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 63 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 919.79 |
| LogP ≤ 5 | 2.76 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 14 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'triple_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 161136512 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.